Navigation Links
MarketsandMarkets Partners With IIR USA for Their Event 'Advanced Biomarker Strategies in Oncology Drug Development'
Date:2/1/2010

DALLAS, February 1 /PRNewswire/ -- The organizers of the Annual Partnerships in Clinical Trials and Central Labs events present Advanced Biomarker Strategies in Oncology Drug Development. The conference is organized at the Grand Hyatt, San Francisco from February 4-5, 2010. This event is FREE for executives from the biotech and pharmaceutical industries.

This two-day program focuses exclusively on the latest developments in oncology biomarkers. It provides an opportunity to interact with the leaders in clinical R&D, oncology, drug development, and translational research. The program aims to deliver and develop solutions, industry standards, and practical applications for biomarker development and validation. This unique program is the first of our three part Target Clinical Trials Series, delivering therapeutic-specific strategies to facilitate execution of successful clinical trials.

For more information on this event, please visit http://www.iirusa.com/targetbiomarkers.

For more information on the Target Clinical Trial Series, visit http://www.clinicaltrialseries.com.

About MarketsandMarkets

MarketsandMarkets is a research and consulting firm that publishes 120 market research reports per year. Each strategically analyzed report contains 250 pages of valuable market data, including more than 100 market data summary tables and in-depth, five-level segmentation for each of the products, services, applications, technologies, ingredients and stakeholders categories. Our reports also analyze about 200 patents, over 50 companies and micro markets that are mutually exclusive and collectively exhaustive. Browse all our 120 titles at http://www.marketsandmarkets.com.

The Global Biomarker Market report published by MarketsandMarkets analyzes the global biomarker tools and services markets over the period 2009-2014. The report studies the major market drivers, restraints, and opportunities for the global biomarker market; and evaluates the major trends in the macro- and micro-markets with respect to different geographic regions.

The global biomarker market is estimated to be $20.5 billion by 2014, growing at a CAGR of 19.7 % from 2009 to 2014. Market growth is driven mainly by the high demand for biomarkers in the field of drug discovery; from the increasing demand from the baby boomer generation in the U.S.; and from Asia's emerging IT industry. Biomarker applications are increasing in cancer diagnosis as novel tools are being developed to increase the discovery speed of cancer biomarkers.

SCOPE AND FORMAT

The report analyzes the global biomarker market into the following segments:

    - Tools Market-(pregenomic biomarkers and technologies, post
      genomic biomarkers and technologies, imaging biomarkers, and others)

    - Services Market-(pre- and post-clinical biomarker services,
      sample preparation, mirna analysis, and others)

    - Application Market-(diagnosis, and drug development and discovery)


    Contact
    Ms. Sunita
    7557 Rambler Road,
    Suite 727, Dallas, TX 75231
    Tel: +1-888-989-8004
    Email: sales@marketsandmarkets.com

SOURCE MarketsandMarkets


'/>"/>
SOURCE MarketsandMarkets
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. MarketsandMarkets Partners with the 9th Annual ePharma Summit to be Held on February 8 -10, 2010
2. MarketsandMarkets: Global Probiotics Market Worth US$32.6 Billion by 2014
3. MarketsandMarkets: Healthcare Information Technology Systems Market to be Worth $53.8 Billion by 2014
4. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
5. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
6. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
7. HistoRx and Radiation Therapy Oncology Group Initiate Brain Tumor Biomarker Research Partnership
8. The Leukemia & Lymphoma Society and Cleveland Clinic Taussig Cancer Institute Announce Groundbreaking Partnership to Accelerate Drug Approvals
9. PDHI Launches ConXus Rewards, Announces Partnership With Hallmark Insights to Support Incentive-Driven Wellness Programs
10. UNICEF Partners With Causes on Facebook to Launch Charity Gift Feature
11. HealthMedias Strongest Single Quarter Results: Growth Driven by Product Enhancements, New Partnerships
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... -- QT Vascular Ltd., together with its subsidiaries (the ... subsidiaries, the "Group"), is pleased to provide an ... ("ÄngioScore") (now owned by Spectranetics Corporation (NASDAQ: ... States Court of Appeals for the ... district court order (the "DCO").   The DCO had ...
(Date:2/10/2016)... Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA ... fourth quarter and full year ended December 31, 2015. ... was a transformational year for Vanda with the continued ... market approval of HETLIOZ for Non-24," said Mihael H. ... Fanapt to our U.S. product portfolio builds on this ...
(Date:2/10/2016)... , Feb. 10, 2016 CSI Specialty Group ... the launch of the Specialty Pharmacy Podcast. A free, ... aimed at providing real-world education, discussion and context amongst ... --> --> The Specialty Pharmacy ... of CSI Specialty Group Suzette DiMascio, CHE, CMCE, CPC, ...
Breaking Medicine Technology:
(Date:2/10/2016)... ... February 10, 2016 , ... As part of its ongoing series ... 2016. Each webinar features a dynamic expert and thoughtful presentation to give attendees ... and facilities. Both events are free to attend, but registration is required. ...
(Date:2/10/2016)... Tenn. (PRWEB) , ... February 10, 2016 , ... ... the American Academy of Emergency Medicine , an emergency medicine professional ... practice management services . , The American Academy of Emergency Medicine, or ...
(Date:2/10/2016)... ... 10, 2016 , ... The Wickman Agency in Garland, TX ... local community. Pledging to select a new beneficiary every 60 days, the agency ... goal is to bring community awareness to important local causes by forming campaigns ...
(Date:2/10/2016)... , ... February 10, 2016 , ... 10 Best ... There were three leading bottled water brand owners that topped the list as a ... connectivity and optimize conversion. The premier brand was Tibet 5100, a top notch water ...
(Date:2/10/2016)... ... ... Dr. Jessica Barron, of Barron Family Dental in Thornton, Colorado , is ... the North Metro Denver area. The new dental practice focuses on comfort where patients ... the most relaxing environment. , While some dental visits can create anxiety for patients, ...
Breaking Medicine News(10 mins):